The impact of multidisciplinary team meetings on patient assessment, management and outcomes in oncology settings: A systematic review of the literature

Cancer Treatment Reviews

Volumn 42, Issue , 2016, Pages 56-72

  Pillay, Brindha ^a   Wootten, Addie C ^a,b,c   Crowe, Helen ^a,b   Corcoran, Niall ^a,b   Tran, Ben ^b   Bowden, Patrick ^a   Crowe, Jane ^a   Costello, Anthony J ^a,b,c  

^a EPWORTH HEALTHCARE   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

^c Australian Prostate Cancer Research   (Australia)

Author keywords

Cancer; Multidisciplinary team meeting; Patient assessment; Patient management; Patient outcomes

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; COMPARATIVE STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; EVIDENCE BASED MEDICINE; HEALTH CARE PERSONNEL; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MEDICAL LITERATURE; META ANALYSIS; MULTIDISCIPLINARY TEAM MEETING; ONCOLOGY; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PATIENT CARE; PATIENT CARE PLANNING; PREOPERATIVE EVALUATION; QUALITY CONTROL; REVIEW; SYSTEMATIC REVIEW; ADJUVANT CHEMOTHERAPY; ADJUVANT RADIOTHERAPY; COST BENEFIT ANALYSIS; DISEASE MANAGEMENT; ECONOMICS; INTERDISCIPLINARY COMMUNICATION; MEDICAL AUDIT; MEDICINE; NEOADJUVANT THERAPY; NEOPLASMS; ORGANIZATION AND MANAGEMENT; PREOPERATIVE CARE; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UTILIZATION;

CHEMOTHERAPY, ADJUVANT; COST-BENEFIT ANALYSIS; DISEASE MANAGEMENT; HUMANS; INTERDISCIPLINARY COMMUNICATION; MEDICAL AUDIT; MEDICINE; NEOADJUVANT THERAPY; NEOPLASM STAGING; NEOPLASMS; PATIENT CARE PLANNING; PATIENT CARE TEAM; PREOPERATIVE CARE; PROSPECTIVE STUDIES; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84955199436     PISSN: 03057372     EISSN: 15321967     Source Type: Journal    
DOI: 10.1016/j.ctrv.2015.11.007     Document Type: Review

References (62)

1. Taylor C., Munro A.J., Glynne-Jones R., Griffith C., Trevatt P., Richards M., et al. Multidisciplinary team working in cancer: what is the evidence?. BMJ 2010, 340:c951.
2. Sundi D., Cohen J.E., Cole A.P., Neuman B.P., Cooper J., Faisal F.A., et al. Establishment of a new prostate cancer multidisciplinary clinic: format and initial experience. Prostate 2015, 75(2):191-199.
3. Magnani T., Valdagni R., Salvioni R., Villa S., Bellardita L., Donegani S., et al. The 6-year attendance of a multidisciplinary prostate cancer clinic in Italy: incidence of management changes. BJU Int 2012, 110(7):998-1003.
4. Pawlik T.M., Laheru D., Hruban R.H., Coleman J., Wolfgang C.L., Campbell K., et al. Evaluating the impact of a single-day multidisciplinary clinic on the management of pancreatic cancer. Ann Surg Oncol 2008, 15(8):2081-2088.
5. Forrest L.M., McMillan D.C., McArdle C.S., Dunlop D.J. An evaluation of the impact of a multidisciplinary team, in a single centre, on treatment and survival in patients with inoperable non-small-cell lung cancer. Br J Cancer 2005, 93(9):977-978.
6. Kelly S.L., Jackson J.E., Hickey B.E., Szallasi F.G., Bond C.A. Multidisciplinary clinic care improves adherence to best practice in head and neck cancer. Am J Otolaryng 2013, 34(1):57-60.
7. Korman H., Lanni T., Shah C., Parslow J., Tull J., Ghilezan M., et al. Impact of a prostate multidisciplinary clinic program on patient treatment decisions and on adherence to NCCN guidelines: the William Beaumont Hospital experience. Am J Clin Oncol 2013, 20(6):778-784.
8. Yopp A., Mansour J., Beg M., Arenas J., Trimmer C., Reddick M., et al. Establishment of a multidisciplinary hepatocellular carcinoma clinic is associated with improved clinical outcome. Ann Surg Oncol 2014, 21(4):1287-1295.
9. Lordan J.T., Karanjia N.D., Quiney N., Fawcett W.J., Worthington T.R. A 10-year study of outcome following hepatic resection for colorectal liver metastases: the effect of evaluation in a multidisciplinary team setting. Eur J Surg Oncol 2009, 35(3):302-306.
10. Stephens M.R., Lewis W.G., Brewster A.E., Lord I., Blackshaw G.R., Hodzovic I., et al. Multidisciplinary team management is associated with improved outcomes after surgery for esophageal. Dis Esophagus 2006, 19(3):164-171.
11. Vinod S.K., Sidhom M.A., Gabriel G.S., Lee M.T., Delaney G.P. Why do some lung cancer patients receive no anticancer treatment?. J Thorac Oncol 2010, 5(7):1025-1032.
12. Freeman R.K., Van Woerkom J.M., Vyverberg A., Ascioti A.J. The effect of a multidisciplinary thoracic malignancy conference on the treatment for patients with esophageal cancer. Ann Thorac Surg 2011, 92:1239-1243.
13. Kurpad R., Kim W., Rathmell W.K., Godley P., Whang Y., Fielding J., et al. A multidisciplinary approach to the management of urologic malignancies: does it influence diagnostic and treatment decisions?. Urol Oncol Semin Original Invest 2011, 29(4):378-382.
14. Wright F.C., De Vito C., Langer B., Hunter A. Multidisciplinary cancer conferences: a systematic review and development of practice standards. Eur J Cancer 2007, 43(6):1002-1010.
15. Chirgwin J., Craike M., Gray C., Watty K., Mileshkin L., Livingston P.M. Does multidisciplinary care enhance the management of advanced breast cancer?: evaluation of advanced breast cancer multidisciplinary team meetings. J Oncol Pract 2010, 6(6):294-300.
16. Butow P., Harrison J.D., Choy E.T., Young J.M., Spillane A., Evans A. Health professional and consumer views on involving breast cancer patients in the multidisciplinary discussion of their disease and treatment plan. Cancer 2007, 110(9):1937-1944.
17. Lamb B., Jalil R., Sevdalis N., Vincent C., Green J. Strategies to improve the efficiency and utility of multidisciplinary team meetings in urology cancer care: a survey study. BMC Health Serv Res 2014, 14:377.
18. Lamb B., Sevdalis N., Mostafid H., Vincent C., Green J. Quality improvement in multidisciplinary cancer teams: an investigation of teamwork and clinical decision-making and cross-validation of assessments. Ann Surg Oncol 2011, 18(13):3535-3543.
19. Lamb B., Sevdalis N., Taylor C., Vincent C., Green J. Multidisciplinary team working across different tumour types: analysis of a national survey. Ann Oncol 2012, 23(5):1293-1300.
20. Lamb B., Taylor C., Lamb J., Strickland S., Vincent C., Green J., Sevdalis N. Facilitators and barriers to teamworking and patient centeredness in multidisciplinary cancer teams: findings of a national study. Ann Surg Oncol 2013, 20(5):1408-1416.
21. Lamb B.W., Sevdalis N., Arora S., Pinto A., Vincent C., Green J.S.A. Teamwork and team decision-making at multidisciplinary cancer conferences: barriers, facilitators, and opportunities for improvement. World J Surg 2011, 35(9):1970-1976.
22. Sarkar S., Arora S., Lamb B., Green J., Sevdalis N., Darzi A. Case review in urology multidisciplinary team meetings: what members think of its functioning. J Clin Urol 2014, 7(6):394-402.
23. Au-Yeung G.H., Aly A., Bui A., Vermeltfoort C.M., Davis I.D. Uptake of oncology multidisciplinary meeting recommendations. Med J Australia 2012, 196(1):36-37.
24. Loh J., Stevens G., Stevens W., Kolbe J. Concordance between thoracic multidisciplinary meeting recommendations for radiation therapy and actual treatment for lung cancer. J Med Imag Radiat Oncol 2012, 56(6):696-702.
25. Palmer J.E., Wales K., Ellis K., Dudding N., Smith J., Tidy J.A. The multidisciplinary colposcopy meeting: recommendations for future service provision and an analysis of clinical decision making. BJOG 2010, 117(9):1060-1066.
26. Santoso J.T., Schwertner B., Coleman R.L., Hannigan E.V. Tumor board in gynecologic oncology. Int J Gynecol Cancer 2004, 14:206-209.
27. Moher D., Liberati A., Tetzlaff J., Altman D.G. The PRISMA Group. Preferred Reporting Items for Systematic Review and Meta-Analyses: the PRISMA statement. BMJ 2009, 339:b2535.
28. Borneman T., Koczywas M., Cristea M., Reckamp K., Sun V., Ferrell B. An interdisciplinary care approach for integration of palliative care in lung cancer. Clin Lung Cancer 2008, 9(6):352-360.
29. Caudron A., Chaby G., Dadban A., Andrejak C., Dhaille F., Bagot M., et al. Multidisciplinary team meetings in oncology: first analysis of benefits and evaluation of activity in a dermatology unit. Eur J Dermatol 2010, 20(6):778-784.
30. Stevens G., Loh J., Kolbe J., Stevens W., Elder C. Comparison of recommendations for radiotherapy from two contemporaneous thoracic multidisciplinary meeting formats: co-located and video conference. Internal Med J 2012, 42(11):1213-1218.
31. Choy E.T., Chiu A., Butow P., Young J., Spillane A. A pilot study to evaluate the impact of involving breast cancer patients in the multidisciplinary discussion of their disease and treatment plan. The Breast 2007, 16:178-189.
32. Hamady Z.Z.R., Mather N., Lansdown M.R., Davidson L., Maclennan K.A. Surgical pathological second opinion in thyroid malignancy: impact on patients' management and prognosis. Eur J Surg Oncol 2005, 31(1):74-77.
33. Riedel R.F., Wang X., McCormack M., Toloza E., Montana G.S., Schreiber G., et al. Impact of a multidisciplinary thoracic oncology clinic on the timeliness of care. J Thorac Oncol 2006, 1(7):692-696.
34. Kee F., Owen T., Leathem R. Offering a prognosis in lung cancer: when is a team of experts an expert team?. J Epidemiol Community Health 2007, 61(4):308-313.
35. Gaba R.C., Kallwitz E.R., Parvinian A., Bui J.T., Von Roenn N.M., Berkes J.L., et al. Imaging surveillance and multidisciplinary review improves curative therapy access and survival in HCC patients. Ann Hepatol 2013, 12(5):766-773.
36. Burton S., Brown G., Daniels I.R., Norman A.R., Mason B., Cunningham D. MRI directed multidisciplinary team preoperative treatment strategy: the way to eliminate positive circumferential margins?. Br J Cancer 2006, 94(3):351-357.
37. Sooriakumaran P., Dick J., Thompson A., Morley R. The central urology multidisciplinary team - is it time to change the referral criteria? An audit of practice in a district general hospital in London. Ann R Coll Surg Engl 2009, 91:700-702.
38. Augestad K.M., Lindsetmo R.-O., Stulberg J., Reynolds H., Senagore A., Champagne B., et al. International preoperative rectal cancer management: staging, neoadjuvant treatment, and impact of multidisciplinary teams. World J Surg 2010, 34(11):2689-2700.
39. Freeman R.K., Van Woerkom J.M., Vyverberg A., Ascioti A.J. The effect of a multidisciplinary thoracic malignancy conference on the treatment of patients with lung cancer. Eur J Cardio-Thorac Surg 2010, 38:1-5.
40. Greer H.O., Frederick P.J., Falls N.M., Tapley E.B., Samples K.L., Kimball K.J., et al. Impact of a weekly multidisciplinary tumor board conference on the management of women with gynecologic malignancies. Int J Gynecol Cancer 2010, 20(8):1321-1325.
41. Keating N.L., Landrum M.B., Lamont E.B., Bozeman S.R., Shulman L.N., McNeil B.J. Tumor boards and the quality of cancer care. J Natl Cancer Inst 2013, 105(2):113-121.
42. Newman E.A., Guest A.B., Helvie M.A., Roubidoux M.A., Chang A.E., Kleer C.G., et al. Changes in surgical management resulting from case review at a breast cancer multidisciplinary tumor board. Cancer 2006, 107(10):2346-2351.
43. Wheless S.A., McKinney K.A., Zanation A.M. A prospective study of the clinical impact of a multidisciplinary head and neck tumor board. Otolaryng Head Neck 2010, 143(5):650-654.
44. Gatcliffe T.A., Coleman R.L. Tumor board: more than treatment planning: a 1-year prospective survey. J Cancer Educ 2008, 23(4):235-237.
45. Acher P.L., Young A.J., Etherington-Foy R., McCahy P.J., Deane A.M. Improving outcomes in urological cancers: the impact of "multidisciplinary team meetings". Int J Surg 2005, 3(2):121-123.
46. Chinai N., Bintcliffe F., Armstrong E.M., Teape J., Jones B.M., Hosie K.B. Does every patient need to be discussed at a multidisciplinary team meeting?. Clin Radiol 2013, 68:780-784.
47. Davies A.R., Deans D.A., Penman I., Plevris J.N., Fletcher J., Wall L., et al. The multidisciplinary team meeting improves staging accuracy and treatment selection for gastro-esophageal cancer. Dis Esophagus 2006, 19(6):496-503.
48. De Ieso P.B., Coward J.I., Letsa I., Schick U., Nandhabalan M., Frentzas S., et al. A study of the decision outcomes and financial costs of multidisciplinary team meetings (MDMs) in oncology. Br J Cancer 2013, 109(9):2295-2300.
49. MacDermid E., Hooton G., MacDonald M., McKay G., Grose D., Mohammed N., et al. Improving patient survival with the colorectal cancer multi-disciplinary team. Colorectal Dis 2009, 11(3):291-295.
50. Boxer M.M., Vinod S.K., Shafiq J., Duggan K.J. Do multidisciplinary team meetings make a difference in the management of lung cancer?. Cancer 2011, 117(22):5112-5120.
51. Bydder S., Nowak A., Marion K., Phillips M., Atun R. The impact of case discussion at a multidisciplinary team meeting on the treatment and survival of patients with inoperable non-small cell lung cancer. Intern Med J 2009, 39(12):838-841.
52. Rao K., Manya K., Azad A., Lawrentschuk N., Bolton D., Davis I.D., et al. Uro-oncology multidisciplinary meetings at an Australian tertiary referral centre: impact on clinical decision-making and implications for patient inclusion. BJU Int 2014, 114(Suppl. 1):50-54.
53. Bouviera A.M., Créhangeb G., Azélieb C., Cheynela N., Jouvea J.L., Bedennea L., et al. Adjuvant treatments for gastric cancer: from practice guidelines to clinical practice. Digest Liver Dis 2014, 46:72-75.
54. Phelip J.M., Molinié F., Delafosse P., Launoy G., Trétarre B., Bara S., et al. A population-based study of adjuvant chemotherapy for stage-II and -III colon cancers. Gastroentérol Clin Biol 2010, 34(2):144-149.
55. Palmer G., Martling A., Cedermark B., Holm T. Preoperative tumour staging with multidisciplinary team assessment improves the outcome in locally advanced primary rectal cancer. Colorectal Dis 2011, 13(12):1361-1369.
56. Brannstrom F., Bjerregaard J.K., Winbladh A., Nilbert M., Revhaug A., Wagenius G., et al. Multidisciplinary team conferences promote treatment according to guidelines in rectal cancer. Acta Oncol 2015, 54(4):447-453.
57. Swellengrebel H.A., Peters E.G., Cats A., Visser O., Blaauwgeers H.G., Verwaal V.J., et al. Multidisciplinary discussion and management of rectal cancer: a population-based study. World J Surg 2011, 35(9):2125-2133.
58. van Hagen P., Spaander M.C., van der Gaast A., van Rij C.M., Tilanus H.W., van Lanschot J.J., et al. Impact of a multidisciplinary tumour board meeting for upper-GI malignancies on clinical decision making: a prospective cohort study. Int J Clin Oncol 2013, 18(2):214-219.
59. Stevens W., Stevens G., Kolbe J., Cox B. Management of stages I and II non-small-cell lung cancer in a New Zealand study: divergence from international practice and recommendations. Intern Med J 2008, 38(10):758-768.
60. Cohen P., Tan A.L., Penman A. The multidisciplinary tumor conference in gynecologic oncology-does it alter management. Int J Gynecol Cancer 2009, 19:1470-1472.
61. Bumm R., Feith M., Lordick F., Herschbach P., Siewert J.R. Impact of multidisciplinary tumor boards on diagnosis and treatment of esophageal cancer. Eur Surg 2007, 39(3):136-140.
62. Wille-Jørgensen P., Sparre P., Glenthøj A., Holck S., Nørgaard Petersen L., Harling H., Stub Hojen H., Bulow S. Result of the implementation of multidisciplinary teams in rectal cancer. Colorectal Dis 2012, 15:410-413.